Beijing, China, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Among the many descriptions of China seen from the outside, the country has gained an increasingly prominent image for itself in 2025 as a "cool" place to visit and live, as reflected in multiple global surveys and in foreign vloggers' videos and comments. As the year draws to a close, the Global Times is launching the "Cool China" series to approach the most iconic events and phenomena of the year through the five senses. In this fourth installment, we will ...

Beijing, China, Dec. 27, 2025 (GLOBE NEWSWIRE) -- "If you are planning on decorating your home for the holidays, everything from artificial Christmas trees to lights, decorative wreaths and rings, you may want to start early." US media recently reported that due to the trade war and tariffs, Christmas goods are in short supply and prices are rising in the US market, forcing many Americans to adjust their holiday budgets. In 2025, a tariff tsunami surged from the east coast of the Pacific, inflicting severe ...

NEWTOWN, Pa., Dec. 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artisans’ Bank. Artisans’ Bank learned of a data breach on or about October 28, 2025. If you would like to discuss this case with a lawyer, please click HERE. About Artisans’ Bank Artisans’ Bank is a Delaware-based community bank offering personal and business banking services. What happened? Around October 28, 2025, Artisans’ Bank was notified that Marquis Softw ...

NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 17, 2026. SO WHAT: If you purchased F5 securities during the Class Period you may be enti ...

集体诉讼案件概述 - 罗森律师事务所提醒在2025年2月21日至2025年8月28日期间购买Telix Pharmaceuticals Ltd (NASDAQ: TLX) 证券的投资者 关于2026年1月9日的重要首席原告截止日期 [1] - 一项针对Telix的证券集体诉讼已经提起 投资者可能有权通过风险代理收费安排获得赔偿 而无需支付任何自付费用或成本 [2][3] 诉讼指控内容 - 指控被告在集体诉讼期间做出了重大虚假和/或误导性陈述 和/或未能披露以下信息 [5] - 指控被告严重夸大了Telix在前列腺癌治疗候选药物方面取得的进展 [5] - 指控被告严重夸大了Telix的供应链及合作伙伴的质量 [5] - 指控结果导致被告关于Telix业务、运营和前景的陈述在所有相关时间均存在重大虚假和误导性 和/或缺乏合理依据 [5] 律师事务所背景 - 罗森律师事务所是一家全球投资者权益律师事务所 专注于证券集体诉讼和股东衍生诉讼 [4] - 该律所曾达成针对中国公司的史上最大证券集体诉讼和解 并在2017年因和解数量被ISS证券集体诉讼服务评为第一名 自2013年以来每年排名前四 [4] - 该律所已为投资者追回数亿美元 仅在2019年就为投资者确保了超过4.38亿美元 [4]

Washington, DC, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article:  https://thinkcarebelieve.blog/2025/12/27/week-49-trump-christmas-in-america/ ThinkCareBelieve, a platform dedicated to fostering thoughtful discourse, compassion, and optimism in American progress, is proud to announce the publication of its latest article, "Week 49 Trump Christmas in America." This timely piece reflects on the achievements and festive spirit of Christmas Week in the Trump 2.0 Administration, highlighti ...

Baltimore, MD, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Wall Street Journal bestselling author and technology analyst James Altucher has released an on-camera video presentation now available for public viewing that examines what he calls a once-in-a-generation convergence between two major technologies. In the presentation, Altucher outlines why he believes this convergence is approaching rapidly — and why it could reshape markets, industries, and global economic structures. The video focuses on Altucher’s long-s ...

GLP-1受体激动剂在体重管理领域的兴起 - 胰高血糖素样肽-1（GLP-1）受体激动剂已成为体重管理领域一个有前景的竞争者，为寻求有效减肥解决方案的个人提供了潜在益处 [1] - 根据美国疾病控制与预防中心（CDC）估计，约42%的美国人目前患有肥胖症（身体质量指数BMI≥30）[4] - 对于肥胖人群，传统的饮食和运动等生活方式改变通常效果不足，而新兴药物有可能逆转导致肥胖的潜在生理途径，从而帮助预防心脏病、肾病、睡眠呼吸暂停等多种慢性疾病的发展 [5] Ozempic（司美格鲁肽）的药物特性与市场动态 - Ozempic是一种用于控制2型糖尿病成人患者血糖水平的注射药物，其活性成分司美格鲁肽在更高剂量下以Wegovy的品牌名称获得美国食品药品监督管理局（FDA）批准用于治疗肥胖及相关疾病 [7] - Ozempic的广泛流行导致了供应短缺，患者和医疗保健提供者都在努力获取这种用于治疗糖尿病和肥胖的高效药物 [3] - 由于Wegovy短缺以及Ozempic减肥效果在社交媒体上的广泛传播，寻求减肥的非2型糖尿病患者对Ozempic的标签外使用有所增加 [8] - Ozempic每周注射一次，相比需要每日或每日两次注射的其他药物，其作用时间更长 [23] - 临床数据显示，服用0.5毫克剂量Ozempic的患者在30周内平均体重减轻约8磅（约3.6公斤）[39]。在另一项为期40周的研究中，接受1毫克剂量的患者平均减重13磅（约5.9公斤），接受2毫克剂量的患者平均减重15磅（约6.8公斤）[40] - Wegovy的推荐剂量为每周2.4毫克，临床试验中，患者在治疗的前20周（5个月）内减去了初始体重的10%，在随后的48周（约11个月）内，体重进一步减轻了8% [41] Ozempic与Wegovy的监管与使用差异 - Ozempic仅获FDA批准用于治疗糖尿病，未被指明为减肥药物，而Wegovy则被专门批准用于体重管理 [33] - Ozempic通常由保险覆盖，而Wegovy经常不被覆盖 [34] - 由于高需求和供应链挑战，Wegovy自推出以来一直存在严重的供应问题，导致许多人转而标签外使用Ozempic进行减肥，这影响了糖尿病患者对Ozempic的可及性 [34] - 虽然使用司美格鲁肽可能有助于在用药期间减轻体重，但大多数人在停药后可能会恢复大部分减掉的体重，研究表明完全停用Ozempic很可能在几个月内导致体重反弹 [35] - GLP-1类药物（如Ozempic）旨在长期使用，作为针对糖尿病和肥胖等慢性疾病的慢性治疗方案 [35] 膳食补充剂PhenQ作为替代方案 - PhenQ被宣传为一种营养减肥产品，可作为Ozempic的替代品，据称能减少不必要的食欲，并针对身体各部位储存的脂肪 [12] - 该产品声称由100%纯天然成分制成，包括咖啡因、左旋肉碱富马酸盐、辣椒提取物粉末、仙人掌提取物、吡啶甲酸铬等 [14][15] - 据称其益处包括抑制食欲、提高能量水平、增强免疫力以及阻止脂肪储存 [18] - 产品定价为：1瓶（30天供应）69.99美元，2瓶加1瓶免费139.99美元，3瓶加2瓶免费209.99美元 [18] - 公司提供60天退款保证，用户可在购买后67天内退回未使用的产品以获得退款（扣除运费）[17] - 用户评价显示，有案例称在使用一个月后减重15磅（约6.8公斤），或在两个月内减重30磅（约13.6公斤）[20][21]

Atlanta, Dec. 27, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we announce the passing of RaceTrac’s long-time leader and Chairman Emeritus, Carl Bolch, Jr.  A beloved husband, father and leader, Bolch possessed an entrepreneurial spirit and strong work ethic, inspiring all he came in contact with throughout his life.    Bolch began his storied career with RaceTrac, a family business founded by his father, in 1967.  He revolutionized the convenience store industry, introducing self-service gas ...

公司重大人事变动 - Senvest Capital Inc 创始人、长期领导者 Victor Mashaal 去世，享年87岁，他曾担任公司总裁、首席执行官和董事会主席 [1] - 公司总裁兼首席执行官职责将由 Richard Mashaal 和财务副总裁 George Malikotsis 共同临时接任，董事会主席职责将由现任董事兼财务秘书 Frank Daniel 临时接任 [3] - 因 Victor Mashaal 去世产生的董事会空缺将由 George Malikotsis 填补 [3] 公司历史与创始人贡献 - Victor Mashaal 于1968年以1万美元初始投资创立公司，用于购买 Sensormatic Electronics Corporation 防盗产品的加拿大代理权 [2] - 创始人不仅开创了加拿大的防盗产品行业，还通过投资 First Choice Communications 并担任其首席执行官，开创了加拿大的付费电视行业 [2] - 创始人带领公司经历了一系列转型，确保了其在不断变化的经济和商业周期中持续成功 [2] 公司当前安排 - 为悼念 Victor Mashaal，公司蒙特利尔办公室将关闭至2026年1月5日 [2] - 公司指定财务副总裁 George Malikotsis 为更多信息的联系人 [4]